An inhaler for the inhalation of powdered pharmaceutical compositions from capsules. The inhaler comprises a chamber for receiving the capsules, which chamber has a greater internal width and a greater length than the diameter and length, respectively, of the capsule and which chamber comprises at one narrow end an air inlet and at the other end an air outlet, so that during inhalation through the inhaler the capsule is set in vibration.
|
1. An inhaler for inhalation of a powdered pharmaceutical composition from a pierceable capsule having a cylindrical side wall and hemispherical ends, said inhaler comprising a mouthpiece portion having a first end adapted for connection to a user, an opposite second end and an axis extending therebetween and a base portion having a first end, an opposite second end and an axis extending therebetween, said second end of said base portion being slidably connected over the second end of said mouthpiece portion such that the portions are in coaxial alignment and are axially slidable with respect to one another from a use position to a capsule piercing position wherein the distance between the first ends of the portions is less than the distance between the first ends of the portions in the use position, said inhaler further including means for normally biasing the portions in the use position but permitting the portions to be slid to the piercing position, said portions defining, in combination, a substantially coaxial cylindrical capsule chamber for receiving the capsule having opposite ends, an internal width in the use position, which is sized to be less than the length of the capsule and an internal length, in the use position, which is sized to be about 1.02 to 2 times the length of the capsule, said base portion defining an air inlet passage terminating in one end of said capsule chamber and the mouthpiece portion defining an air outlet passage fluidically communicating with the other end of said capsule chamber, the internal cross-section of the air inlet passage being smaller than the internal cross-section of said air outlet passage which is itself smaller than the internal width of the capsule chamber, said capsule chamber being coaxially aligned with said air inlet and air outlet passages, said mouthpiece portion defining apertures extending into said capsule chamber between said opposite ends, said apertures being located to be between the first and second ends of the base portion in the piercing position and said base portion including means therein, between said first and second ends, for aligning with said apertures and piercing, via said apertures, the cylindrical side wall of the capsule when said portions are in the capsule piercing position.
2. An inhaler of
3. An inhaler of
|
This is a continuation of copending application Ser. No. 905,693, filed Sept. 9, 1986, now abandoned; which, in turn, is a continuation of application Ser. No. 681,008, filed Dec. 13, 1984, now abandoned.
This invention is directed to an inhaler. More particularly, this invention is directed to an inhaler for the inhalation of powdered pharmaceutical preparations from capsules.
Inhalers for the inhalation of pharmaceutical preparations packed in capsules wherein the capsules are moved during the inhalation, are already known. An inhaler of this type is known, for example, from German Offenlegungsschrift 1,566,604. The inhaler described therein comprises a device for receiving the capsules which has propeller-like wings and is mounted coaxially with the longitudinal axis of the apparatus. During inhalation, the device with the capsule is set rotating by the apparatus.
Whereas in the inhaler described above the pharmaceutical capsule is fixed in a movable part of the apparatus and is moved therewith, French patent application Ser. No. 2,146,202 describes an inhalation apparatus with a flat cylindrical chamber in which only the capsule itself moves. The capsule, which is opened at its ends, is driven by air flowing tangentially inwards and rotates about its transverse axis during inhalation.
Both of these known inhalers have the major disadvantage that the pharmaceutical composition is expelled unevenly. Some capsules are emptied virtually entirely while others still contain considerable amounts of pharmaceutical preparation after the inhalation process. This is the case particularly with very finely divided (micronized) pharmaceutical preparations.
It is an object of the invention to provide an inhaler.
It is also an object of the invention to provide an inhaler for the inhalation of powdered pharmaceutical preparations from conventional capsules.
It is a further object of the invention to provide an inhaler for the inhalation of powdered pharmaceutical preparations from capsules in which opened capsules are vibrated by an air current during the inhalation.
These and other objects of the invention will become more apparent from the description below.
FIG. 1 represents a longitudinal, cross-sectional view of an embodiment of the invention;
FIG. 2 represents a cross-sectional view along the line A--A in FIG. 1; and
FIG. 3 represents a cross-sectional view of an embodiment of the invention in which the chamber is laterally mounted and can be opened and closed by means of a movable plate.
The inhaler according to the invention not only permits a more reliable expulsion of the pharmaceutical preparation with a low standard deviation, but it also has the additional advantage of better fragmentation. In fact, the micronized pharmaceutical preparations in the capsules have a tendency to form clumps. These clumps are therapeutically undesirable as the pharmaceutical preparation should be as finely divided as possible. Whereas only inadequate fragmentation is achieved with the known inhalers, the clumps are largely destroyed when the inhaler according to the invention is used.
The inhaler according to the invention has a chamber for receiving the capsules, the internal width of this chamber being from about 1.1 to 2.5, preferably from about 1.1 to 2.2, more particularly from about 1.2 to 1.6, times the size of the diameter of the capsule while the length of this chamber is from about 1.02 to 2, preferably from about 1.04 to 1.8, more particularly from about 1.1 to 1.6, times the length of the capsule. The internal width of the chamber must be less than the length of the capsule.
The capsules themselves normally consist of hard gelatine. The length to width (diameter) ratio of such capsules is generally from about 1.5:1 to 4:1, preferably from about 2:1 to 3:1. Typically such capsules are from about 1 to 3 cm, especially from about 1.5 to 2.5 cm, in length.
An air inlet aperture is appropriately provided in the center of the base of the chamber. If the air inlet aperture is not in the center of the base of the chamber, it must be arranged so that the cap of the capsule can close it off as will be appreicated from the description below of the method of operation. The aperture is smaller than the diameter of the capsule, its diameter being preferably from about 0.05 to 0.5 times the internal width of the chamber. The aperture is preferably circular.
The chamber is conveniently cylindrical. However, it may also have an oval or polygonal cross-section.
An air outlet is located in that part of the chamber which is opposite the air inlet aperture and must be of a configuration such that the capsule is not sucked against the outlet aperture during inhalation so as to close it off. There are various possible ways to prevent the outlet aperture from being closed off by the capsule. For example, the wall of the capsule chamber opposite the air inlet aperture may be in the form of a perforated plate, or projecting parts may be provided which are sufficiently close together for their spacing to be less than the diameter of the capsule. Furthermore, one or more aperture may be provided as outlet apertures at the upper end of the side walls. The total cross-section available for the outflow of air from the capsule chamber is advantageously greater than the air inlet aperture cross-section to ensure that the air charged with the pharmaceutical substance can flow out with as little interference as possible.
The air mixed with pharmaceutical substance in the chamber is conveyed to the mouth of the user by means of a mouthpiece. The mouthpiece, which is generally tubular, possibly somewhat flattened, may be mounted axially or at an angle to the axis of the chamber or may be offset laterally from the axis of the chamber.
The inhaler according to the invention preferably consists of at least two parts which are held together by a screw or pushed-in connection. The parts are shaped so that when they are taken apart, the chamber is opened and the capsule can be inserted or removed. If the chamber is laterally mounted, an axially movable cover may be provided which opens or closes the chamber dependent upon its position and which, in the closed position, forms part of the side walls of the chamber. If the part of the inhaler containing the chamber is cylindrical, the cover of the chamber may also be in the form of a sleeve which is rotatable about the axis of the inhaler and which, in a certain position, enables the capsule to be put in or taken out.
For the inhalation process. the capsule must be perforated at two points, one point near each end. The hemispherical caps of the capsule should not be damaged in the process. This is important because the capsule or its cap acts as a sort of valve. Due to the pressure conditions, the capsule is pulled against the inlet aperture against the air flowing in and partly closes off this aperture. As the user continues to suck on the mouthpiece, a vacuum is produced in the capsule chamber by means of which the capsule is drawn towards the air outlet along with the incoming air. The vacuum now produced at the air inlet causes the capsule to be drawn towards the inlet aperture again. The entire procedure is repeated in rapid succession as long as the user continues to inhale through the mouthpiece, and this causes the capsule to vibrate strongly.
The capsule may be opened outside the inhaler. However, it is more convenient to mount cutting tools on the inhaler with which the capsule can be opened inside the chamber.
The invention can perhaps be better understood by making reference to the drawings:
The embodiment of the inhaler according to the invention shown in FIG. 1 consists of lower part 1 and mouthpiece 2, which are fitted together. The lower part 1 contains air inlet channel 3 and a cutting mechanism 4, which is held in its normal position by a spring element 5. The mouthpiece 2 contains capsule chamber 6. Projections 7, which limit the clearance of a capsule 15, project into the extension 6a of the capsule chamber 6. A perforated plate 8 prevents any fragments of capsule 15, for example, from being inhaled.
The inhaler can be compressed axially counter to the pressure of a spring element 9, whereupon the upper edge of the lower part 1 reaches position 10. In this position blades or points 11 of the cutting mechanism 4 are able to penetrate through openings 12 into the capsule chamber 6 and open a capsule 15 fixed therein.
FIG. 2 shows the capsule chamber extension 6a with the projections 7 which limit the play of the capsule 15 of the actual capsule chamber 6.
FIG. 3 shows a laterally mounted capsule chamber 13 and an axially movable element 14 which serves to open and close capsule chamber 13 and simultaneously forms part of the side wall.
In order to use the inhaler as shown in FIG. 1, the lower part 1 and mouthpiece 2 are pulled apart, the capsule 15 is inserted, and the two parts 1 and 2 of the inhaler are fitted together. After mouthpiece 2 has been pushed inwards against lower part 1 into position 10 counter to the spring element 9, the cutting mechanism 4 is actuated and then released. The inhaler returns to the position shown in FIG. 1 under pressure from the spring element 9. Inhalation then takes place by breathing in through the mouthpiece 2.
The preceding specific embodiments are illustrative of the practice of the invention. It is to be understood, however, that other expedients known to those skilled in the art or disclosed herein, may be employed without departing from the spirit of the invention or the scope of the appended claims.
Patent | Priority | Assignee | Title |
10188614, | May 03 2002 | Nektar Therapeutics | Particulate materials |
10195139, | Dec 26 2006 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application |
10220165, | May 27 2011 | Boehringer Ingelheim International GmbH | Inhalator and capsule for an inhalator |
10245394, | Oct 25 2006 | Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices | |
10441733, | Jun 25 2012 | RESPIRA THERAPEUTICS, INC | Powder dispersion devices and methods |
10500355, | May 21 2012 | Boehringer Ingelheim International GmbH | System composed of inhaler and capsule |
10525216, | Feb 21 2012 | RESPIRA THERAPEUTICS, INC | Powder dispersion methods and devices |
10525218, | Nov 28 2006 | OPTINOSE INC | Nasal delivery devices |
10682476, | Feb 21 2012 | RESPIRA THERAPEUTICS, INC | Powder inhaler, system and methods |
10888675, | Feb 24 2016 | Boehringer Ingelheim International GmbH | Inhaler |
10945972, | May 03 2002 | Nektar Therapeutics | Particulate materials |
11103449, | Apr 04 2014 | ORPHAI THERAPEUTICS INC | Inhalable rapamycin formulation for treating age-related conditions |
11123289, | Oct 08 2013 | ORPHAI THERAPEUTICS INC | Rapamycin for the treatment of lymphangioleiomyomatosis |
11224705, | Feb 24 2016 | Boehringer Ingelheim International GmbH | Inhaler |
11260184, | Nov 30 2016 | PHILIP MORRIS PRODUCTS S A | Inhaler with sized cavity |
11471622, | Nov 30 2016 | PHILIP MORRIS PRODUCTS S A | Inhaler with swirl end plug |
11471623, | Feb 21 2012 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
11491143, | Oct 07 2014 | ORPHAI THERAPEUTICS INC | Inhalable rapamycin formulation for the treatment of pulmonary hypertension |
11571531, | Feb 23 2005 | OPTINOSE INC | Powder delivery devices |
11648199, | Apr 04 2014 | ORPHAI THERAPEUTICS INC | Inhalable rapamycin formulation for treating age-related conditions |
11744797, | Oct 08 2013 | ORPHAI THERAPEUTICS INC | Rapamycin for the treatment of lymphangioleiomyomatosis |
11744967, | Sep 26 2017 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Intranasal delivery devices |
5048514, | Jul 07 1989 | Somova S.p.A. | Inhaler for medicaments contained in capsules |
5161524, | Aug 02 1991 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
5271439, | Feb 20 1992 | Semi-Bulk Systems, Inc. | System for unloading powdered or granular materials |
5351683, | Apr 12 1990 | CHIESI FARMACEUTICI S.P.A. | Device for the administration of powdered medicinal substances |
5388572, | Oct 26 1993 | Glaxo Wellcome Inc | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
5388573, | Dec 02 1993 | Glaxo Wellcome Inc | Dry powder inhalator medicament carrier |
5435301, | Nov 24 1992 | Bayer Aktiengesellschaft | Powder inhaler having dispersing, discharge, and dwell-time chambers, along with an acceleration channel |
5460173, | Mar 03 1993 | Glaxo Wellcome Inc | Dry powder inhaler medicament carrier |
5595175, | Aug 16 1991 | Novartis AG | Inhaler for administration of powdery substances |
5619985, | Aug 08 1994 | Unisia Jecs Corporation; Dott Limited Company | Inhaler type medicine administering device |
5642727, | Jul 25 1995 | Sarnoff Corporation | Inhaler apparatus using a tribo-electric charging technique |
5669378, | Dec 21 1995 | Inhaling device | |
5669973, | Jun 06 1995 | Sarnoff Corporation | Apparatus for electrostatically depositing and retaining materials upon a substrate |
5673686, | Feb 02 1994 | HOVIONE INTER LTD | Medicament inhaler and method |
5714007, | Jun 06 1995 | Sarnoff Corporation | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
5740794, | Sep 21 1994 | Novartis Pharma AG | Apparatus and methods for dispersing dry powder medicaments |
5752505, | Mar 21 1996 | Hitachi, LTD | Inhalation-type medicine delivery device |
5780014, | Apr 14 1995 | Novartis Pharma AG | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
5785049, | Sep 21 1994 | Novartis Pharma AG | Method and apparatus for dispersion of dry powder medicaments |
5857456, | Jun 10 1996 | Sarnoff Corporation | Inhaler apparatus with an electronic means for enhanced release of dry powders |
5871010, | Jun 10 1996 | Sarnoff Corporation | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
5901703, | Feb 06 1995 | Hitachi, LTD | Medicine administering device for nasal cavities |
5947118, | Jun 03 1993 | Boehringer Ingelheim KG | Capsule holder |
5989217, | Mar 21 1996 | Hitachi, LTD | Medicine administering device for nasal cavities |
5993783, | Mar 13 1996 | Novartis Pharma AG | Method and apparatus for pulmonary administration of dry powder α1-antitrypsin |
5997848, | Mar 07 1994 | Novartis Pharma AG | Methods and compositions for pulmonary delivery of insulin |
6007630, | Jun 06 1995 | Delsys Pharmaceutical Corporation | Method and apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
6051256, | Mar 07 1994 | Novartis Pharma AG | Dispersible macromolecule compositions and methods for their preparation and use |
6074688, | Jun 06 1996 | Delsys Pharmaceutical Corporation | Method for electrostatically depositing a medicament powder upon predefined regions of a substrate |
6089228, | Sep 21 1994 | Novartis Pharma AG | Apparatus and methods for dispersing dry powder medicaments |
6149774, | Jun 10 1998 | Sarnoff Corporation | AC waveforms biasing for bead manipulating chucks |
6257233, | Jun 04 1998 | Novartis Pharma AG | Dry powder dispersing apparatus and methods for their use |
6298846, | Jan 30 1997 | Hitachi, LTD | Suction type medicator |
6319541, | Jun 06 1995 | Delsys Pharmaceutical Corporation | Method and apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
6423344, | Mar 07 1994 | Novartis Pharma AG | Dispersible macromolecule compositions and methods for their preparation and use |
6475351, | Jun 10 1998 | Delsys Pharmaceutical Corporation | AC waveforms biasing for bead manipulating chucks |
6509006, | Jul 08 1992 | Novartis Pharma AG | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
6536426, | Dec 08 1999 | Mederio AG | Active walls |
6543448, | Sep 21 1994 | Novartis Pharma AG | Apparatus and methods for dispersing dry powder medicaments |
6546929, | Jun 04 1998 | Novartis Pharma AG | Dry powder dispersing apparatus and methods for their use |
6582728, | Jul 08 1992 | Novartis Pharma AG | Spray drying of macromolecules to produce inhaleable dry powders |
6591833, | Jun 10 1996 | Delsys Pharmaceutical Corp. | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
6592904, | Mar 07 1994 | Novartis Pharma AG | Dispersible macromolecule compositions and methods for their preparation and use |
6679256, | Dec 17 1999 | Novartis Pharma AG | Systems and methods for extracting powders from receptacles |
6681767, | Jul 02 1991 | Novartis Pharma AG | Method and device for delivering aerosolized medicaments |
6685967, | Mar 07 1994 | Novartis Pharma AG | Methods and compositions for pulmonary delivery of insulin |
6705313, | Jan 16 2002 | PH&T S P A | Device usable in the treatment of affections of the airways |
6722365, | Dec 08 1999 | Mederio AG | Active walls |
6732732, | Apr 16 2001 | CORREGIDOR THERAPEUTICS, INC | Inhalation device and method |
6737045, | Mar 07 1994 | Novartis Pharma AG | Methods and compositions for the pulmonary delivery insulin |
6797258, | Jul 08 1992 | Novartis Pharma AG | Compositions and methods for the pulmonary delivery of aerosolized macromolecules |
6802313, | Jun 06 1995 | Sarnoff Corporation | Method and apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
6901929, | Jun 04 1998 | Novartis Pharma AG | Dry powder dispersing apparatus and methods for their use |
6921527, | Jul 08 1992 | Novartis Pharma AG | Composition for pulmonary administration comprising a drug and a hydrophobic amino acid |
6923979, | Apr 27 1999 | MICRODOSE THERAPEUTX, INC | Method for depositing particles onto a substrate using an alternating electric field |
7032593, | Aug 14 2000 | CIVITAS THERAPEUTICS, INC | Inhalation device and method |
7097827, | Apr 14 1995 | Novartis AG | Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
7138141, | Mar 07 1994 | Novartis AG | Dispersible macromolecule compositions and methods for their preparation and use |
7146978, | Apr 16 2001 | CORREGIDOR THERAPEUTICS, INC | Inhalation device and method |
7278419, | Jan 29 1993 | Aradigm Corporation | Method for treating diabetes mellitus in a patient |
7278425, | Apr 16 2001 | CORREGIDOR THERAPEUTICS, INC | Inhalation device and method |
7278982, | Mar 27 2003 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Powder medicine applicator for nasal cavity |
7284553, | Dec 12 2002 | BOEHRINGER INGELHEIM PHARMA GMBH & CO KG | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient |
7422013, | Jun 04 1998 | Novartis Pharma AG | Dry powder dispersing apparatus and methods for their use |
7448375, | Jan 29 1993 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
7521069, | Mar 07 1994 | Novartis AG | Methods and compositions for pulmonary delivery of insulin |
7559325, | Apr 09 2003 | BGP Products Operations GmbH | Aerosolization apparatus with air inlet shield |
7632533, | Apr 27 1999 | MICRODOSE THERAPEUTX, INC | Method and apparatus for producing uniform small portions of fine powders and articles thereof |
7744925, | Dec 02 1994 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
7780991, | Dec 02 1994 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
7785631, | Dec 02 1994 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
7806117, | Jun 07 2006 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Peroral powder delivery device |
7870856, | Apr 11 2006 | Boehringer Ingelheim International GmbH | Inhaler |
7878193, | Jan 14 2003 | BOEHRINGER INGELHELM INTERNATIONAL GMBH | Capsule for taking an active substance which can be inhaled |
8001965, | Jan 14 2003 | Boehringer Ingelheim International GmbH | Capsule for taking an active substance which can be inhaled |
8006695, | Nov 10 2004 | Cipla Limited | Inhaler |
8069851, | Apr 09 2003 | BGP Products Operations GmbH | Aeorosolization apparatus with air inlet shield |
8109267, | May 16 2006 | Hovione Holding Limited | Simple inhaler |
8161969, | Jun 04 1998 | Novartis AG | Dry powder dispersing apparatus and methods for their use |
8173168, | Mar 07 1994 | Novartis Pharma AG | Dispersible macromolecule compositions and methods for their preparation and use |
8196578, | Apr 15 2006 | Boehringer Ingelheim International GmbH | Inhaler |
8273330, | May 03 2002 | Nektar Therapeutics | Particulate materials |
8298575, | Aug 05 1998 | Boehringer Ingelheim Pharma GmbH & Co. KG | Two-part capsule to accept pharmaceutical preparations for powder inhalers |
8327844, | Mar 03 1999 | OPTINOSE INC | Nasal delivery method |
8337817, | Dec 26 2006 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Preparation for transnasal application |
8337895, | Jun 30 2000 | Novartis AG | Spray drying process control of drying kinetics |
8435554, | Feb 21 2003 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Compositons for nasal administration of pharmaceuticals |
8496002, | Jun 12 2007 | CORREGIDOR THERAPEUTICS, INC | Powder inhaler devices |
8555877, | Mar 03 1999 | OPTINOSE INC | Nasal delivery device |
8555878, | Mar 03 1999 | OPTINOSE INC | Nasal delivery device |
8573197, | Oct 25 2006 | Novartis AG | Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices |
8609630, | Sep 07 2005 | Bebaas, Inc. | Vitamin B12 compositions |
8662076, | Jan 11 2005 | BOEHRINGER INGELHEIM PHARMA GMBH & CO KG | Two-part capsule with pre-closure for housing pharmaceutical preparations for powder inhalers |
8673360, | Aug 10 2004 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Compositions that enable rapid-acting and highly absorptive intranasal administration |
8677992, | Apr 26 2010 | HOVIONE TECHNOLOGY LIMITED | Simple capsule-based inhaler |
8802149, | Dec 31 1996 | Novartis Pharma AG | Systems and processes for spray drying hydrophobic and hydrophilic components |
8827946, | Jul 31 2009 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Intranasal granisetron and nasal applicator |
8869794, | Apr 09 2003 | BGP Products Operations GmbH | Aerosolization apparatus with capsule puncturing member |
8899229, | Feb 23 2005 | OPTINOSE INC | Powder delivery devices |
9010325, | Nov 28 2006 | OPTINOSE INC | Nasal delivery devices |
9072857, | Mar 03 1999 | OPTINOSE INC | Nasal delivery device |
9101539, | May 15 2009 | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD | Intranasal pharmaceutical compositions with improved pharmacokinetics |
9119932, | Mar 03 1999 | OPTINOSE INC | Nasal delivery device |
9138410, | Feb 21 2003 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions for nasal administration of pharmaceuticals |
9144652, | Feb 23 2005 | OPTINOSE INC | Powder delivery devices |
9604017, | Nov 15 2005 | BOEHRINGER INGELHEIM PHARMA GMBH & CO KG | Needle for piercing a powder capsule for inhalation |
9700529, | May 03 2002 | Nektar Therapeutics | Particulate materials |
9913951, | Jun 22 2015 | Gerresheimer Regensburg GMBH | Device for opening capsules |
RE45404, | Mar 27 2003 | Shin Nippon Biomedical Laboratories, Ltd. | Powder medicine applicator for nasal cavity |
RE47526, | Apr 09 2003 | BGP Products Operations GmbH | Aerosolization apparatus with air inlet shield |
Patent | Priority | Assignee | Title |
2569720, | |||
2722935, | |||
3507277, | |||
3837341, | |||
3906950, | |||
3918451, | |||
3991761, | Mar 18 1974 | Inhaler for powdered medicaments | |
3999751, | Jun 17 1975 | Balloon carrousel | |
4069819, | Apr 13 1973 | Societa Farmaceutici S.p.A. | Inhalation device |
4338931, | Apr 27 1979 | Device for the quick inhalation of drugs in powder form by humans suffering from asthma |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 02 1987 | Boehringer Ingelheim KG | (assignment on the face of the patent) | / | |||
Aug 09 1989 | BRADLEY, DANIEL W | UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | ASSIGNMENT OF ASSIGNORS INTEREST | 005153 | /0474 |
Date | Maintenance Fee Events |
Mar 25 1993 | M183: Payment of Maintenance Fee, 4th Year, Large Entity. |
Apr 05 1993 | ASPN: Payor Number Assigned. |
Jan 17 1996 | ASPN: Payor Number Assigned. |
Jan 17 1996 | RMPN: Payer Number De-assigned. |
May 19 1997 | M184: Payment of Maintenance Fee, 8th Year, Large Entity. |
Jun 11 2001 | M185: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Dec 26 1992 | 4 years fee payment window open |
Jun 26 1993 | 6 months grace period start (w surcharge) |
Dec 26 1993 | patent expiry (for year 4) |
Dec 26 1995 | 2 years to revive unintentionally abandoned end. (for year 4) |
Dec 26 1996 | 8 years fee payment window open |
Jun 26 1997 | 6 months grace period start (w surcharge) |
Dec 26 1997 | patent expiry (for year 8) |
Dec 26 1999 | 2 years to revive unintentionally abandoned end. (for year 8) |
Dec 26 2000 | 12 years fee payment window open |
Jun 26 2001 | 6 months grace period start (w surcharge) |
Dec 26 2001 | patent expiry (for year 12) |
Dec 26 2003 | 2 years to revive unintentionally abandoned end. (for year 12) |